Quantbot Technologies’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2
| Closed | -$352 | – | 1726 |
|
|
2025
Q4 | $352 | Sell |
2
-688
| -100% | -$112K | ﹤0.01% | 1648 |
|
|
2025
Q3 | $96.7K | Sell |
690
-907
| -57% | -$123K | ﹤0.01% | 1435 |
|
|
2025
Q2 | $201K | Sell |
1,597
-12,540
| -89% | -$1.56M | 0.01% | 1235 |
|
|
2025
Q1 | $1.93M | Buy |
14,137
+11,665
| +472% | +$1.67M | 0.06% | 464 |
|
|
2024
Q4 | $378K | Buy |
2,472
+1,694
| +218% | +$286K | 0.01% | 901 |
|
|
2024
Q3 | $151K | Buy |
+778
| New | +$163K | 0.01% | 1081 |
|
|
2024
Q2 | – | Sell |
-4,108
| Closed | -$886K | – | 1447 |
|
|
2024
Q1 | $886K | Buy |
4,108
+3,445
| +520% | +$807K | 0.05% | 560 |
|
|
2023
Q4 | $172K | Sell |
663
-28
| -4% | -$6.88K | 0.01% | 1051 |
|
|
2023
Q3 | $178K | Buy |
+691
| New | +$185K | 0.01% | 941 |
|
|
2023
Q1 | – | Sell |
-907
| Closed | -$251K | – | 1560 |
|
|
2022
Q4 | $251K | Sell |
907
-2,323
| -72% | -$656K | 0.02% | 810 |
|
|
2022
Q3 | $862K | Buy |
3,230
+3,037
| +1,574% | +$645K | 0.07% | 429 |
|
|
2022
Q2 | $39K | Sell |
193
-5,044
| -96% | -$1.03M | ﹤0.01% | 1341 |
|
|
2022
Q1 | $1.1M | Buy |
5,237
+5,137
| +5,137% | +$1.12M | 0.1% | 314 |
|
|
2021
Q4 | $23K | Sell |
100
-4,710
| -98% | -$1.21M | ﹤0.01% | 1197 |
|
|
2021
Q3 | $1.36M | Buy |
+4,810
| New | +$1.58M | 0.1% | 292 |
|
|
2021
Q1 | – | Sell |
-9,158
| Closed | -$2.24M | – | 1419 |
|
|
2020
Q4 | $2.24M | Buy |
+9,158
| New | +$2.36M | 0.23% | 125 |
|
|
2020
Q1 | – | Sell |
-6,003
| Closed | -$1.78M | – | 933 |
|
|
2019
Q4 | $1.78M | Sell |
6,003
-6,572
| -52% | -$1.82M | 0.18% | 162 |
|
|
2019
Q3 | $2.93M | Buy |
12,575
+11,875
| +1,696% | +$2.77M | 0.29% | 90 |
|
|
2019
Q2 | $163K | Buy |
+700
| New | +$162K | 0.02% | 640 |
|
|
2019
Q1 | – | Sell |
-2,902
| Closed | -$873K | – | 1016 |
|
|
2018
Q4 | $873K | Buy |
+2,902
| New | +$926K | 0.09% | 308 |
|
|
2018
Q3 | – | Sell |
-5,774
| Closed | -$1.68M | – | 1265 |
|
|
2018
Q2 | $1.68M | Buy |
5,774
+2,746
| +91% | +$772K | 0.11% | 269 |
|
|
2018
Q1 | $829K | Buy |
3,028
+2,706
| +840% | +$840K | 0.07% | 358 |
|
|
2017
Q4 | $102K | Sell |
322
-3,587
| -92% | -$1.15M | 0.01% | 840 |
|
|
2017
Q3 | $1.22M | Buy |
3,909
+3,699
| +1,761% | +$1.1M | 0.12% | 237 |
|
|
2017
Q2 | $56K | Sell |
210
-7,558
| -97% | -$2M | 0.01% | 890 |
|
|
2017
Q1 | $2.12M | Sell |
7,768
-784
| -9% | -$222K | 0.22% | 106 |
|
|
2016
Q4 | $2.42M | Buy |
+8,552
| New | +$2.54M | 0.27% | 85 |
|
|
2016
Q2 | – | Sell |
-247
| Closed | -$64K | – | 1064 |
|
|
2016
Q1 | $64K | Buy |
+247
| New | +$65.2K | 0.01% | 828 |
|
|
2015
Q3 | – | Sell |
-1,727
| Closed | -$697K | – | 1199 |
|
|
2015
Q2 | $697K | Sell |
1,727
-3,086
| -64% | -$1.24M | 0.12% | 174 |
|
|
2015
Q1 | $2.03M | Buy |
+4,813
| New | +$1.9M | 0.5% | 32 |
|
|
2014
Q4 | – | Sell |
-739
| Closed | -$244K | – | 1132 |
|
|
2014
Q3 | $244K | Sell |
739
-5,198
| -88% | -$1.71M | 0.03% | 620 |
|
|
2014
Q2 | $1.87M | Buy |
+5,937
| New | +$1.79M | 0.3% | 91 |
|
Other funds holding BIIB
VCM
VPM
Quantbot Technologies's BIIB Position: Q1 2026 in Review
Quantbot Technologies sold out of Biogen (BIIB) in Q1 2026, closing a stake of 2 shares — an estimated $352 sold.
Quantbot Technologies first reported a position in BIIB in Q2 2014 and held it in 32 quarters. The position peaked at $2.93M in Q3 2019. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Quantbot Technologies reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
- Quantbot Technologies sold 2 Biogen shares in Q1 2026, an estimated $352.
- Quantbot Technologies first reported a position in Biogen in Q2 2014 and held it in 32 quarters.
- Quantbot Technologies's Biogen position peaked at $2.93M in Q3 2019.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.